The Ministry of Health and Family Welfare has, vide Notification dated 16th October 2019, after consultation with the Drugs Technical Advisory Board, specified that the Ultrasound equipment device intended for external or internal use in human beings qualifies as “Drug” under section 3(b) of the Drugs and Cosmetics Act, 1940 (Sec 3b-Defines Drugs) with effect from November 01, 2019.
Click here to read the Notification
The scope of the orders is extended to apply to goods or articles domestically manufactured or imported before the date of commencement of this Order
This Notification shall apply with effect from the date of publication in the Official Gazette (i.e. from the Previous Year 2024-25) and accordingly shall be
It is clarified that implicating Customs Brokers as co-noticee in a routine manner, in matters involving interpretation of statute, must be avoided unless the element
This notification underscores the importance of forming an internal committee as mandated by the Act and emphasizes the need for compliance from all offices.
Stay up-to-date with the latest regulatory developments from Legality Alerts, directly in your inbox. Never miss another important regulatory compliance news alert.
Solutions
Resources
